Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bargagli, F. Monaci, P. Rottoli (Siena, Italy). The anlysis of trace elements in BAL of patients with diffuse lung diseases and Langherans cell histiocytosis. Eur Respir J 2007; 30: Suppl. 51, 3478

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 The proteomic analysis of BAL from patients with langerhans cell histiocytosis (LCH) Source: Eur Respir J 2007; 30: Suppl. 51, 245s Year: 2007 Adult pulmonary Langerhans' cell histiocytosis Source: Eur Respir J 2006; 27: 1272-1285 Year: 2006 Ventilation disorders dynamics and morphological changes in patients with pulmonary Langerhans cell histiocytosis (PLCH) Source: International Congress 2015 – IIPs: orphan Year: 2015 Multiple cystic lung diseases Source: Eur Respir Mon 2011; 54: 46-83 Year: 2011 Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 An integrated approach in the diagnosis of smoking-related interstitial lung diseases Source: Eur Respir Rev 2012 21:207-217 Year: 2012 Langerhans cell histiocytosis: is it an ILD? Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021 Airway dendritic cell phenotypes in inflammatory diseases of the human lung Source: Eur Respir J 2007; 30: 878-886 Year: 2007 Smoking-related interstitial lung diseases: a concise review Source: Eur Respir J 2001; 17: 122-132 Year: 2001 Genetic landscape of adult Langerhans cell histiocytosis with lung involvement Source: Eur Respir J, 55 (2) 1901190; 10.1183/13993003.01190-2019 Year: 2020 The use of immunohistochemical stains to identify Langerhans cells in pulmonary histiocytosis Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Bronchoalveolar lavage cytokine profile in patients with Pulmonary Langerhans Cell Histiocytosis differs from other interstitial lung diseases Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases Year: 2020 A case with pulmonary histiocytosis X and lung cancer Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Proteomic analysis of antioxidant proteins in bronchoalveolar lavage of patients with pulmonary Langerhans-cell histiocytosis Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Adult pulmonary Langerhans‘ cell histiocytosis and lung cancer Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009 Chemotherapy in patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Clonality analysis in lymphocytic interstitial pneumonia and other lymphoproliferative disorders in the lung Source: Eur Respir J 2006; 28: Suppl. 50, 306s Year: 2006 Pulmonary hypertension in pulmonary Langerhans’ cell histiocytosis Source: Eur Respir Mon 2012; 57: 161-165 Year: 2012